Navigation and service

You are here:Rote-Hand-Briefe and Information Letters

Dear Doctor Letter (Rote-Hand-Brief) on Maxipime® (cefepime): Risk of serious neurologic adverse events in patients with renal impairment

Date 2018.06.18
Active substance cefepime

Information is circulated on the risk of serious adverse events, including encephalopathy, in patients with renal impairment who received doses that exceeded the recommendations.